Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
CE ›
CELLCITY
Trademark search for:
CELLCITY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-02-23 — Application filed
2021-05-13 — Sn assigned for sect 66a appl from ib
2021-05-17 — Application filed
2021-05-21 — Application filed
2021-09-17 — Assigned to examiner
2021-09-23 — Final disposition recorded
2021-09-24 — Office action issued
2021-10-07 — Office action issued
2021-10-07 — Office action issued
2021-10-30 — Office action issued
2022-04-06 — Office action issued
2022-04-06 — Correspondence received in law office
2022-04-06 — Teas/email correspondence entered
2022-05-09 — Correspondence received in law office
2022-05-09 — Teas/email correspondence entered
2022-05-24 — Office action issued
2022-05-24 — Office action issued
2022-05-24 — Office action issued
2022-10-19 — Notification of possible opposition created, to be sent to ib
2022-10-19 — Notification of possible opposition sent to ib
2022-11-04 — Teas request for reconsideration received
2022-11-04 — Correspondence received in law office
2022-11-04 — Teas/email correspondence entered
2022-11-07 — Notification of possible opposition - processed by ib
2022-11-30 — Examiners amendment -written
2022-11-30 — Examiners amendment e-mailed
2022-11-30 — Notification of examiners amendment e-mailed
2022-11-30 — Examiner's amendment entered
2022-12-29 — Approved for pub - principal register
2023-01-11 — Notification of notice of publication e-mailed
2023-01-11 — Notice of start of opposition period created, to be sent to ib
2023-01-11 — Notification of possible opposition sent to ib
2023-01-31 — Published for opposition
2023-01-31 — Official gazette publication confirmation e-mailed
2023-01-31 — Notification processed by ib
2023-03-01 — Extension of time to oppose received
2023-04-12 — Extension of time to oppose process - terminated
2023-04-26 — Notification of notice of publication e-mailed
2023-04-26 — Notice of start of opposition period created, to be sent to ib
2023-04-26 — Notification of possible opposition sent to ib
2023-05-16 — Published for opposition
2023-05-16 — Official gazette publication confirmation e-mailed
2023-05-16 — Notification processed by ib
2023-05-17 — Withdrawn from issue - managing attorney request
2023-06-16 — Limitation of goods received from ib
2023-06-27 — Registered-principal register
2023-06-27 — Notice of registration confirmation emailed
2023-09-27 — Final disposition recorded
2023-12-14 — Correction under section 7 - processed
2023-12-14 — Limitation from the ib examined and entered
2023-12-14 — Final disposition recorded
2023-12-14 — Final disposition recorded
2024-01-07 — Final disposition recorded
2024-01-16 — Notice of updated registration confirmation emailed
2024-01-16 — Notice of updated registration confirmation emailed
2024-01-22 — Notice of updated registration confirmation emailed
2025-07-10 — Partial invalidation of reg ext protection created
2025-11-11 — Final status recorded
2025-11-30 — Death of international registration
2025-11-30 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
EVORION Biotechnologies GmbH
DE
EVORION Biotechnologies GmbH
DE
EVORION Biotechnologies GmbH
DE
Correspondent
Leigh Ann Lindquist SUGHRUE MION, PLLC 2000 Pennsylvania Avenue NW, Suite 9000 Washington, DC 20006 UNITED STATES
Filing Details
Filing Date:
2021-02-23
Status Date:
2025-11-11
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.